Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core
Authors:
- Gaspard GerschenfeldGGGaspard Gerschenfeld
- Guillaume TurcGTGuillaume Turc
- Michael ObadiaMOMichael Obadia
- Nicolas ChaussonNCNicolas Chausson
- Arturo ConsoliACArturo Consoli
- Stephane OlindoSOStephane Olindo
- Jildaz CaroffJCJildaz Caroff
- Gaultier MarnatGMGaultier Marnat
- Raphael BlancRBRaphael Blanc
- Wagih Ben HassenWHWagih Ben Hassen
- Pierre SenersPSPierre Seners
- Benoit GuillonBGBenoit Guillon
- 9 July 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 103 (1) , e209398
Abstract
IV tenecteplase is an alternative to alteplase before mechanical thrombectomy (MT) in patients with large-vessel occlusion (LVO) ischemic stroke. Little data are available on its use in patients with large ischemic core. We aimed to compare the efficacy and safety of both thrombolytics in this population. We conducted a retrospective analysis of patients with anterior circulation LVO strokes and diffusion-weighed imaging Alberta Stroke Program Early CT Score (DWI-ASPECTS) ≤5 treated with tenecteplase or alteplase before MT from the TETRIS (tenecteplase) and ETIS (alteplase) French multicenter registries. Primary outcome was reduced disability at 3 months (ordinal analysis of the modified Rankin scale [mRS]). Safety outcomes were 3-month mortality, parenchymal hematoma (PH), and symptomatic intracranial hemorrhage (sICH). We used propensity score overlap weighting to reduce baseline differences between treatment groups. We analyzed 647 patients (tenecteplase: n = 194; alteplase: n = 453; inclusion period 2015-2022). Median (interquartile range) age was 71 (57-81) years, with NIH Stroke Scale score 19 (16-22), DWI-ASPECTS 4 (3-5), and last seen well-to-IV thrombolysis and puncture times 165 minutes (130-226) and 260 minutes (203-349), respectively. After MT, the successful reperfusion rate was 83.1%. After propensity score overlap weighting, all baseline variables were well balanced between both treatment groups. Compared with patients treated with alteplase, patients treated with tenecteplase had better 3-month mRS (common odds ratio [OR] for reduced disability: 1.37, 1.01-1.87, p = 0.046) and lower 3-month mortality (OR 0.52, 0.33-0.81, p < 0.01). There were no significant differences between thrombolytics for PH (OR 0.84, 0.55-1.30, p = 0.44) and sICH incidence (OR 0.70, 0.42-1.18, p = 0.18). Our data are encouraging regarding the efficacy and reassuring regarding the safety of tenecteplase compared with that of alteplase in bridging therapy for patients with LVO strokes and a large ischemic core in routine clinical care. These results support its consideration as an alternative to alteplase in bridging therapy for patients with large ischemic cores. NCT03776877 (ETIS registry) and NCT05534360 (TETRIS registry). This study provides Class III evidence that patients with anterior circulation LVO stroke and DWI-ASPECTS ≤5 treated with tenecteplase vs alteplase before MT experienced better functional outcomes and lower mortality at 3 months.Keywords
This publication has 45 references indexed in Scilit:
- Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion StrokeJAMA Neurology, 2023
- Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic StrokeJAMA Neurology, 2023
- Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic StrokeJAMA, 2021
- Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic StrokeJAMA, 2021
- Time from I.V. Thrombolysis to Thrombectomy and Outcome in Acute Ischemic StrokeAnnals of Neurology, 2020
- Overlap WeightingJAMA, 2020
- Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic CoresJAMA Neurology, 2019
- Multiple imputation using chained equations: Issues and guidance for practiceStatistics in Medicine, 2010
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Predicting functional outcome and survival after acute ischemic strokeJournal of Neurology, 2002